Logo image of SBC

SBC MEDICAL GROUP HOLDINGS I (SBC) Stock Fundamental Analysis

USA - NASDAQ:SBC - US73245B1070 - Common Stock

4.195 USD
+0.03 (+0.6%)
Last: 10/17/2025, 5:20:02 PM
4.195 USD
0 (0%)
After Hours: 10/17/2025, 5:20:02 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SBC. SBC was compared to 100 industry peers in the Health Care Providers & Services industry. While SBC has a great health rating, its profitability is only average at the moment. SBC has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

SBC had positive earnings in the past year.
In the past year SBC has reported a negative cash flow from operations.
SBC Yearly Net Income VS EBIT VS OCF VS FCFSBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

Looking at the Return On Assets, with a value of 10.57%, SBC belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
SBC has a Return On Equity of 13.63%. This is amongst the best in the industry. SBC outperforms 81.00% of its industry peers.
The Return On Invested Capital of SBC (22.45%) is better than 96.00% of its industry peers.
Industry RankSector Rank
ROA 10.57%
ROE 13.63%
ROIC 22.45%
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SBC Yearly ROA, ROE, ROICSBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30

1.3 Margins

SBC has a better Profit Margin (17.71%) than 100.00% of its industry peers.
The Operating Margin of SBC (38.45%) is better than 100.00% of its industry peers.
SBC has a better Gross Margin (76.97%) than 91.00% of its industry peers.
Industry RankSector Rank
OM 38.45%
PM (TTM) 17.71%
GM 76.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SBC Yearly Profit, Operating, Gross MarginsSBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

SBC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, SBC has less shares outstanding
Compared to 1 year ago, SBC has an improved debt to assets ratio.
SBC Yearly Shares OutstandingSBC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
SBC Yearly Total Debt VS Total AssetsSBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 6.67 indicates that SBC is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 6.67, SBC belongs to the best of the industry, outperforming 89.00% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that SBC is not too dependend on debt financing.
SBC's Debt to Equity ratio of 0.03 is amongst the best of the industry. SBC outperforms 81.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 6.67
ROIC/WACC2.65
WACC8.47%
SBC Yearly LT Debt VS Equity VS FCFSBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

SBC has a Current Ratio of 3.98. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
SBC's Current ratio of 3.98 is amongst the best of the industry. SBC outperforms 89.00% of its industry peers.
SBC has a Quick Ratio of 3.95. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of SBC (3.95) is better than 89.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.98
Quick Ratio 3.95
SBC Yearly Current Assets VS Current LiabilitesSBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 50M 100M 150M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.06% over the past year.
SBC shows a strong growth in Revenue. In the last year, the Revenue has grown by 74.40%.
EPS 1Y (TTM)39.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.01%
Revenue 1Y (TTM)74.4%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.35%

3.2 Future

Based on estimates for the next years, SBC will show a very negative growth in Earnings Per Share. The EPS will decrease by -10.18% on average per year.
The Revenue is expected to decrease by -6.13% on average over the next years.
EPS Next Y-27.17%
EPS Next 2Y-10.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-16.5%
Revenue Next 2Y-6.13%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

SBC Yearly Revenue VS EstimatesSBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 50M 100M 150M 200M
SBC Yearly EPS VS EstimatesSBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.2 0.4 0.6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.32, which indicates a very decent valuation of SBC.
Compared to the rest of the industry, the Price/Earnings ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 93.00% of the companies listed in the same industry.
SBC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.40.
The Price/Forward Earnings ratio is 8.65, which indicates a very decent valuation of SBC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 94.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SBC to the average of the S&P500 Index (22.94), we can say SBC is valued rather cheaply.
Industry RankSector Rank
PE 9.32
Fwd PE 8.65
SBC Price Earnings VS Forward Price EarningsSBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SBC is valued cheaper than 97.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.85
SBC Per share dataSBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

SBC's earnings are expected to decrease with -10.18% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-10.18%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SBC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SBC MEDICAL GROUP HOLDINGS I

NASDAQ:SBC (10/17/2025, 5:20:02 PM)

After market: 4.195 0 (0%)

4.195

+0.03 (+0.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-11 2025-11-11
Inst Owners0.62%
Inst Owner ChangeN/A
Ins Owners89.24%
Ins Owner Change0%
Market Cap435.78M
Analysts80
Price Target7.91 (88.56%)
Short Float %1.19%
Short Ratio2.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.84%
Min EPS beat(2)-85.33%
Max EPS beat(2)89.02%
EPS beat(4)2
Avg EPS beat(4)-21.1%
Min EPS beat(4)-98.74%
Max EPS beat(4)89.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.51%
Min Revenue beat(2)-9.04%
Max Revenue beat(2)-3.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.89%
Min Revenue beat(4)-22.64%
Max Revenue beat(4)-3.9%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)19.23%
PT rev (3m)28.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.54%
EPS NY rev (1m)-1.52%
EPS NY rev (3m)-27.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.82%
Valuation
Industry RankSector Rank
PE 9.32
Fwd PE 8.65
P/S 2.32
P/FCF N/A
P/OCF N/A
P/B 1.78
P/tB 1.83
EV/EBITDA 3.85
EPS(TTM)0.45
EY10.73%
EPS(NY)0.48
Fwd EY11.56%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS1.81
BVpS2.35
TBVpS2.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.57%
ROE 13.63%
ROCE 28.42%
ROIC 22.45%
ROICexc 56.12%
ROICexgc 60%
OM 38.45%
PM (TTM) 17.71%
GM 76.97%
FCFM N/A
ROA(3y)11.06%
ROA(5y)N/A
ROE(3y)17.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.1
Cap/Depr 96.72%
Cap/Sales 1.65%
Interest Coverage 980.59
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.98
Quick Ratio 3.95
Altman-Z 6.67
F-Score5
WACC8.47%
ROIC/WACC2.65
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.01%
EPS Next Y-27.17%
EPS Next 2Y-10.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)74.4%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-18.35%
Revenue Next Year-16.5%
Revenue Next 2Y-6.13%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y42.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-567.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-391.7%
OCF growth 3YN/A
OCF growth 5YN/A